Secondary <i>vs.</i> primary pituitary xanthogranulomas: which yellow is more mellow?-Reference-Cited by-同舟云学术

Secondary <i>vs.</i> primary pituitary xanthogranulomas: which yellow is more mellow?

Published:2024 Issue:3 Volume:71 Page:285-293
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Miljic Dragana¹²,Pekic Sandra¹²,Doknic Mirjana¹²,Stojanovic Marko¹²,Ilic Sasa²,Djurovic Marina Nikolic¹²,Jemuovic Zvezdana²,Milojevic Toplica³,Milicevic Mihailo¹³,Jovanovic Marija¹⁴,Medic Stojanoska Milica⁵,Carić Bojana⁶,Radic Nevena²,Medenica Sanja⁷,Manojlovic Gacic Emilija⁸,Petakov Milan¹²

Affiliation:

1. Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia

2. Clinic for Endocrinology, Diabetes and Metabolic Diseases, University Clinical Center of Serbia, Belgrade 11000, Serbia

3. Clinic for Neurosurgery, University Clinical Center of Serbia, Belgrade 11000, Serbia

4. Center for Magnetic Resonance Imaging, University Clinical Center of Serbia, Belgrade 11000, Serbia

5. University of Novi Sad, Faculty of Medicine, Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Vojvodina, Novi Sad 21000, Serbia

6. Faculty of Medicine, University of Banja Luka, University Clinical Center of Republic of Srpska, Banja Luka 78101, Bosnia and Herzegovina

7. School of Medicine, University of Montenegro, Podgorica, Montenegro, Department of Endocrinology, Internal Medicine Clinic, Clinical Center of Montenegro, Podgorica 81110, Montenegro

8. Institute of Pathology, Faculty of Medicine, University of Belgrade, Belgrade 11000, Serbia

Publisher

Japan Endocrine Society

Link

https://www.jstage.jst.go.jp/article/endocrj/71/3/71_EJ23-0398/_pdf

Reference22 articles.

1. 1 Shirataki K, Okada S, Matsumoto S (1988) Histopathological study of the “cholesterol granuloma reaction” in the sellar and juxta-sellar tumors. No To Shinkei 40: 133–139 (In Japanese).

2. 2 Paulus W, Honegger J, Keyvani K, Fahlbusch R (1999) Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 97: 377–382.

3. 3 Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, et al. (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61: 215–225.

4. 4 Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, et al. (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46: 161–165.

5. 5 Oikonomou E, Barreto DC, Soares B, De Marco L, Buchfelder M, et al. (2005) Beta-catenin mutations in craniopharyngiomas and pituitary adenomas. J Neurooncol 73: 205–209.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic Transsphenoidal Drainage for Rathke Cleft Cyst With Sellar Xanthogranuloma - Successful Cyst Drainage and Prevention of Postoperative Cerebrospinal Fluid Leakage: 2-Dimensional Operative Video;Operative Neurosurgery;2024-08-14